Hypertrophic cardiomyopathy differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
{{Hypertrophic cardiomyopathy}}
{{Hypertrophic cardiomyopathy}}


'''Editors-In-Chief:''' C. Michael Gibson, M.S., M.D. [mailto:mgibson@perfuse.org], Martin S. Maron, M.D., and Barry J. Maron, M.D.
'''Editors-In-Chief:''' C. Michael Gibson, M.S., M.D. [mailto:mgibson@perfuse.org]


==Overview==
==Overview==

Revision as of 23:04, 7 August 2011

Hypertrophic Cardiomyopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypertrophic Cardiomyopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypertrophic cardiomyopathy differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypertrophic cardiomyopathy differential diagnosis

CDC on Hypertrophic cardiomyopathy differential diagnosis

Hypertrophic cardiomyopathy differential diagnosis in the news

Blogs on Hypertrophic cardiomyopathy differential diagnosis

Directions to Hospitals Treating Hypertrophic cardiomyopathy

Risk calculators and risk factors for Hypertrophic cardiomyopathy differential diagnosis

Editors-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Clinical diagnosis of HCM is most easily and readily established with 2-dimensional echocardiography, by imaging the hypertrophied but nondilated LV chamber, in the absence of another cardiac or systemic disease capable of producing the magnitude of hypertrophy evident.

Differential Diagnosis

HCM must be distinguished from the following disorders:

1. Athlete's heart

Several criteria can be used to distinguish these two entities:

The degree of left ventricular wall thickness
  • In athlete's heart the LVH is symmetric and less than or equal to 12 mm
  • Rarely the LV thickness can be 14-16 mm and this makes it difficult to distinguish from HOCM. Athletes who engage in strength training may develop this pattern, ahtletes who engage in endurance training do not.
  • If the degree of thickening is out of proportion to the type and intensity of exercise, this suggests HOCM
The pattern of left ventricular wall thickness
  • Athleste's heart is symmetric
  • HOCM is more often asymmetric, but may in some cases be symmetric
The left ventricular cavity size
  • HOCM has smaller LV cavitary dimensions

2. Hypertensive heart disease

3. Aortic stenosis

4. Cardiac amyloidosis

References

Template:WH Template:WS